As reported by UK Authority, NHS England unveils plans for a significant digital procurement framework aimed at transforming primary care, with potential extensions and cross-sector applications, signalling a significant step forward in healthcare technology.
It has published a market opportunity notice indicating that the framework could have a value of up to £297 million, running from January of next year for an initial 12 months, but with an extension of three years if condition precedents are met.
The scope covers a number of capabilities, including care navigation for patients; online consultations and patient requests; reporting of the requests; cross-organisational appointment booking; prescription ordering; video consultations; communication management; and enabling patients to view content from their electronic patient records.
The framework will be open for use beyond the health service by bodies including the Ministry of Justice and Ministry of Defence and their executive agencies, and entities of the Home Office.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment